UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Kinetics and Mechanism of Mammalian Mitochondrial Ribosome Assembly

Cell reports (Cambridge), 2018-02, Vol.22 (7), p.1935-1944

2018

Volltextzugriff (PDF)

De novo lipogenesis represents a therapeutic target in mutant Kras non‐small cell lung cancer

The FASEB journal, 2018-06, Vol.32 (12), p.7018-7027

2018

Volltextzugriff (PDF)

Podocyte-specific KLF6 primes proximal tubule CaMK1D signaling to attenuate diabetic kidney disease

Nature communications, 2024-09, Vol.15 (1), p.8038-19, Article 8038

2024

Volltextzugriff (PDF)

Zng1 is a GTP-dependent zinc transferase needed for activation of methionine aminopeptidase

Cell reports (Cambridge), 2022-05, Vol.39 (7), p.110834-110834, Article 110834

2022

Volltextzugriff (PDF)

Epithelial to mesenchymal transition is a determinant of sensitivity of non-small-cell lung carcinoma cell lines and xenografts to epidermal growth factor receptor inhibition

Cancer research (Chicago, Ill.), 2005-10, Vol.65 (20), p.9455-9462

2005

Volltextzugriff (PDF)

The HSP-RTK-Akt axis mediates acquired resistance to Ganetespib in HER2-positive breast cancer

Cell death & disease, 2021-01, Vol.12 (1), p.126-126, Article 126

2021

Volltextzugriff (PDF)

Integrative multi-omics profiling reveals cAMP-independent mechanisms regulating hyphal morphogenesis in Candida albicans

PLoS pathogens, 2021-08, Vol.17 (8), p.e1009861-e1009861

2021

Volltextzugriff (PDF)

Kinetic analysis of epidermal growth factor receptor somatic mutant proteins shows increased sensitivity to the epidermal growth factor receptor tyrosine kinase inhibitor, erlotinib

Cancer research (Chicago, Ill.), 2006-08, Vol.66 (16), p.8163-8171

2006

Volltextzugriff (PDF)

Kinase switching in mesenchymal-like non-small cell lung cancer lines contributes to EGFR inhibitor resistance through pathway redundancy

Clinical & experimental metastasis, 2008-12, Vol.25 (8), p.843-854

2008

Volltextzugriff (PDF)

Comparative gene co-expression network analysis of epithelial to mesenchymal transition reveals lung cancer progression stages

BMC cancer, 2017-12, Vol.17 (1), p.830-830, Article 830

2017

Volltextzugriff (PDF)

Novel replisome-associated proteins at cellular replication forks in EBV-transformed B lymphocytes

PLoS pathogens, 2019-12, Vol.15 (12), p.e1008228

2019

Volltextzugriff (PDF)

Feedback mechanisms promote cooperativity for small molecule inhibitors of epidermal and insulin-like growth factor receptors

Cancer research (Chicago, Ill.), 2008-10, Vol.68 (20), p.8322-8332

2008

Volltextzugriff (PDF)

Decoupling of Nrf2 Expression Promotes Mesenchymal State Maintenance in Non-Small Cell Lung Cancer

Cancers, 2019-10, Vol.11 (10), p.1488

2019

Volltextzugriff (PDF)

Rapamycin synergizes with the epidermal growth factor receptor inhibitor erlotinib in non–small-cell lung, pancreatic, colon, and breast tumors

Molecular cancer therapeutics, 2006-11, Vol.5 (11), p.2676-2684

2006

Volltextzugriff (PDF)

Inhibition of phosphoenolpyruvate carboxykinase blocks lactate utilization and impairs tumor growth in colorectal cancer

Cancer & metabolism, 2019-08, Vol.7 (1), p.8-8, Article 8

2019

Volltextzugriff (PDF)

AACR Special Conference on Epithelial-Mesenchymal Transition and Cancer Progression and Treatment

Cancer research (Chicago, Ill.), 2010-10, Vol.70 (19), p.7360-7364

2010

Volltextzugriff (PDF)

Development of a 5-FU modified miR-129 mimic as a therapeutic for non-small cell lung cancer

Molecular therapy. Oncolytics, 2023-03, Vol.28, p.277-292

2023

Volltextzugriff (PDF)

Loss of homotypic cell adhesion by epithelial-mesenchymal transition or mutation limits sensitivity to epidermal growth factor receptor inhibition

Molecular cancer therapeutics, 2007-02, Vol.6 (2), p.532-541

2007

Volltextzugriff (PDF)

Pulse-chase SILAC–based analyses reveal selective oversynthesis and rapid turnover of mitochondrial protein components of respiratory complexes

The Journal of biological chemistry, 2020-02, Vol.295 (9), p.2544-2554

2020

Volltextzugriff (PDF)

Mass Spectrometry and Pharmacological Approaches to Measuring Cooption and Reciprocal Activation of Receptor Tyrosine Kinases

Proteomes, 2023-06, Vol.11 (2), p.20

2023

Volltextzugriff (PDF)

Inactivation of Akt by the epidermal growth factor receptor inhibitor erlotinib is mediated by HER-3 in pancreatic and colorectal tumor cell lines and contributes to erlotinib sensitivity

Molecular cancer therapeutics, 2006-08, Vol.5 (8), p.2051-2059

2006

Volltextzugriff (PDF)

Phosphotyrosine Signaling Networks in Epidermal Growth Factor Receptor Overexpressing Squamous Carcinoma Cells

Molecular & cellular proteomics, 2005-04, Vol.4 (4), p.356-376

2005

Volltextzugriff (PDF)

Altered Transcriptional Control Networks with Trans-Differentiation of Isogenic Mutant-KRas NSCLC Models

Frontiers in oncology, 2014-01, Vol.4, p.344-344

2014

Volltextzugriff (PDF)

SREBP1 regulates mitochondrial metabolism in oncogenic KRAS expressing NSCLC

The FASEB journal, 2020-08, Vol.34 (8), p.10574-10589

2020

Volltextzugriff (PDF)

Imaging with mass spectrometry, the next frontier in sphingolipid research? A discussion on where we stand and the possibilities ahead

Chemistry and physics of lipids, 2019-03, Vol.219, p.1-14

2019

Volltextzugriff (PDF)

1 – 25 von 596

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(509)
Mit Volltextzugriff
(530)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(3)
... seit 90 Tagen
(8)

Menü

Weitere Dienste

Einstellungen

Kinetics and Mechanism of Mammalian Mitochondrial Ribosome Assembly

De novo lipogenesis represents a therapeutic target in mutant Kras non‐small cell lung cancer

Podocyte-specific KLF6 primes proximal tubule CaMK1D signaling to attenuate diabetic kidney disease

Zng1 is a GTP-dependent zinc transferase needed for activation of methionine aminopeptidase

Epithelial to mesenchymal transition is a determinant of sensitivity of non-small-cell lung carcinoma cell lines and xenografts to epidermal growth factor receptor inhibition

The HSP-RTK-Akt axis mediates acquired resistance to Ganetespib in HER2-positive breast cancer

Integrative multi-omics profiling reveals cAMP-independent mechanisms regulating hyphal morphogenesis in Candida albicans

Kinetic analysis of epidermal growth factor receptor somatic mutant proteins shows increased sensitivity to the epidermal growth factor receptor tyrosine kinase inhibitor, erlotinib

Kinase switching in mesenchymal-like non-small cell lung cancer lines contributes to EGFR inhibitor resistance through pathway redundancy

Comparative gene co-expression network analysis of epithelial to mesenchymal transition reveals lung cancer progression stages

Novel replisome-associated proteins at cellular replication forks in EBV-transformed B lymphocytes

Feedback mechanisms promote cooperativity for small molecule inhibitors of epidermal and insulin-like growth factor receptors

Decoupling of Nrf2 Expression Promotes Mesenchymal State Maintenance in Non-Small Cell Lung Cancer

Rapamycin synergizes with the epidermal growth factor receptor inhibitor erlotinib in non–small-cell lung, pancreatic, colon, and breast tumors

Inhibition of phosphoenolpyruvate carboxykinase blocks lactate utilization and impairs tumor growth in colorectal cancer

AACR Special Conference on Epithelial-Mesenchymal Transition and Cancer Progression and Treatment

Development of a 5-FU modified miR-129 mimic as a therapeutic for non-small cell lung cancer

Loss of homotypic cell adhesion by epithelial-mesenchymal transition or mutation limits sensitivity to epidermal growth factor receptor inhibition

Pulse-chase SILAC–based analyses reveal selective oversynthesis and rapid turnover of mitochondrial protein components of respiratory complexes

Mass Spectrometry and Pharmacological Approaches to Measuring Cooption and Reciprocal Activation of Receptor Tyrosine Kinases

Inactivation of Akt by the epidermal growth factor receptor inhibitor erlotinib is mediated by HER-3 in pancreatic and colorectal tumor cell lines and contributes to erlotinib sensitivity

Phosphotyrosine Signaling Networks in Epidermal Growth Factor Receptor Overexpressing Squamous Carcinoma Cells

Altered Transcriptional Control Networks with Trans-Differentiation of Isogenic Mutant-KRas NSCLC Models

SREBP1 regulates mitochondrial metabolism in oncogenic KRAS expressing NSCLC

Imaging with mass spectrometry, the next frontier in sphingolipid research? A discussion on where we stand and the possibilities ahead

Suchergebnisse filtern